These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3258143)

  • 61. The taxonomy and antimicrobial susceptibility of Haemophilus species in clinical specimens.
    Golberg R; Washington JA
    Am J Clin Pathol; 1978 Dec; 70(6):899-904. PubMed ID: 364976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM; Zemcov SJ; Campbell ME
    J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
    Floyd-Reising SA; Kelley SG; Hindler JA; Young LS
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):301-6. PubMed ID: 3472704
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE; Wickerhoff-Minoggio T
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R; Andrews JM; Danks G
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activities of new quinoline derivatives against genital pathogens.
    Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The adverse effects of fluoroquinolones.
    Smith CR
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract]   [Full Text] [Related]  

  • 68. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
    Wise R; Andrews JM; Ashby JP; Matthews RS
    Antimicrob Agents Chemother; 1988 May; 32(5):617-22. PubMed ID: 3134843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Heterogeneity of strains of Haemophilus influenzae of genital and neonatal origin: analysis of capsular serotypes, biotypes and electrophoretic profiles of external membrane proteins and LPS].
    Pinon G; Quentin R; Dubray G
    Ann Inst Pasteur Microbiol; 1986; 137B(2):195-205. PubMed ID: 3500732
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance.
    Pérez-Vázquez M; Román F; Varela MC; Cantón R; Campos J
    J Antimicrob Chemother; 2003 Jan; 51(1):147-51. PubMed ID: 12493800
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Symposium on antimicrobial agents. The quinolones.
    Walker RC; Wright AJ
    Mayo Clin Proc; 1987 Nov; 62(11):1007-12. PubMed ID: 3312850
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
    Kemmerich B; Borner K; Pennington JE
    Antimicrob Agents Chemother; 1987 Mar; 31(3):417-20. PubMed ID: 3495234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative pharmacokinetics of new quinolones.
    Lode H; Höffken G; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reimnitz D; Borner K; Koeppe P
    Drugs; 1987; 34 Suppl 1():21-5. PubMed ID: 3481323
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Susceptibility of Bordetella pertussis to five quinolone antimicrobic drugs.
    Appleman ME; Hadfield TL; Gaines JK; Winn RE
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):131-3. PubMed ID: 2892608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro activity of the new 4-quinolone compound Ro 23-6240.
    Clarke AM; Zemcov SJ
    Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interaction between quinolones and caffeine.
    Staib AH; Stille W; Dietlein G; Shah PM; Harder S; Mieke S; Beer C
    Drugs; 1987; 34 Suppl 1():170-4. PubMed ID: 3481318
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Ullmann U
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Haemophilus influenzae and genital infections: which role for biotype IV?].
    Pinon G; Quentin R
    Presse Med; 1985 May; 14(19):1101. PubMed ID: 3158976
    [No Abstract]   [Full Text] [Related]  

  • 80. Isolation of Haemophilus influenzae and Haemophilus parainfluenzae from genital-tract specimens with a selective culture medium.
    Sturm AW
    J Med Microbiol; 1986 Jun; 21(4):349-52. PubMed ID: 3487655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.